All News CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
8.23 ^USD	+0.73%		-0.60%	-31.42%

Apr. 16	CareDx Appoints John Hanna as CEO, President	MT
Apr. 16	CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	Apr. 19	BU
CareDx Appoints John Hanna as CEO, President	Apr. 16	MT
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	Apr. 16	BU
CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	Apr. 16	CI
CareDx, Inc Appoints John W. Hanna as President and Member of the Board of Directors	Apr. 16	CI
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	Apr. 09	RE
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	Apr. 09	BU
CareDx Appoints Bryan Riggsbee to Its Board of Directors	Mar. 11	BU
CareDx, Inc Appoints Bryan Riggsbee to Its Board of Directors	Mar. 11	CI
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K	Mar. 11	PU
CareDx : Corporate Presentation February 2024	Mar. 01	PU
CareDx: Q4 Earnings Snapshot	Feb. 28	AQ
Transcript : CareDx, Inc, Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (CDNA) CAREDX Reports Q4 Revenue $65.6M, vs. Street Est of $64.1M	Feb. 28	MT
CareDx, Inc Provides Revenue Guidance for the Full Year of 2024	Feb. 28	CI
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	BU
CareDx, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference	Feb. 27	BU
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	BU
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings	Feb. 21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News CareDx, Inc

Equities

CDNA

US14167L1035

All News

Filters